Learn about multiple sclerosis, its symptoms, causes, and treatment options. Understand how early diagnosis helps in managing ...

Because of how unpredictable MS symptom flares can be, columnist Desiree Lama often finds herself living a sheltered life.

Metis' MTS-004 was safe and eased symptoms of pseudobulbar affect in people with MS and other neurological disorders, trial data show.

First UK patient with multiple sclerosis treated with CAR T cell therapy: United Kingdom Wednesday, October 29, 2025, 15:00 Hrs [IST] A patient with multiple sclerosis has become ...

"I was listening to a podcast where a woman talked about her experience of living with two uteruses. And I was like ‘d*mn, ...

Making health conversations accessible and empowering for everyone, Dr. Scott McMahon announces the season two return of the ...

Late-breaking Phase III data show ianalumab, Novartis’ dual-targeted antibody, reduced disease activity and patient burden in ...

An estimated 10 million Americans aged 50 and older have osteoporosis, a condition that causes bone loss and a higher risk of ...

For decades, a vicious cycle held our healthcare system hostage: treat illness when it appears, then manage complications as ...

NEPTUNUS-1 and NEPTUNUS-2 achieved primary objective of reduced disease activity and provided clinically meaningful benefit1 Data showed consistent improvements across secondary outcome measures, and ...

Johnson & Johnson today announced plans to initiate the first head-to-head study comparing FcRn blockers for patients with generalized myasthenia gravis (gMG), which aims to affirm IMAAVYtm ...

Compelling results set new clinical standard in generalized myasthenia gravis (gMG), increasing confidence in the Company’s registrational KYSA-6 Phase 3 MG trial. 100% of patie ...